Key Takeaways
Key players operating in the acellular dermal matrices market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. These companies collectively hold a significant share of the market.
Growing demand for acellular dermal matrices from reconstructive...
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Acellular dermal matrices are widely used for reconstructive surgeries involving the repair...
The global acellular dermal matrices market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Acellular dermal matrices offer many advantages to other skin substitutes. They provide an instantly...
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
· Strength: Acellular dermal matrices offer effective tissue...
Acellular dermal matrices are sheets of human dermal tissue that are acellular and collagen-based biologic products used to reinforce and support soft tissue repairs or to replace damaged or inadequate integumental tissue. They are commonly used for facial and abdominal wall reconstruction and breast reconstruction surgeries.
The global acellular dermal matrices market is estimated to be valued...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian